View Article |
Dexamethasone for Covid-19: a literature review
Endah Sekar Palupi1, Nurul Faiza2, Chairil Anjasmara Robo Putra3.
SARS-COV2 commonly known as COVID-19 is a disease that has become a global pandemic since the beginning of the year in 2020. Symptoms that are related to COVID-19 are fever, cough, chest pain, weakness, a nd difficulty breathing. Some cases of patients also experience mild symptoms such as diarrhea, dizziness, nausea, and vomiting. COVID-19 firstly found with pneumonia patients has never been diagnosed in China. Pneumonia or acute respiratory disease is the main disease that supports the indication of COVID-19. The treatment has been given to COVID-19 patients one of which is antibiotics and other drugs as a symptom reliever. Dexamethasone is a corticosteroid drug given to patients with an acute respiratory system. In this article, we will discuss dexamethasone for therapy COVID-19 with some reviews of studies that have been done in patients with acute respiratory systems.
Affiliation:
- Airlangga University, Indonesia
- Airlangga University, Indonesia
- Airlangga University, Indonesia
|
|
Indexation |
Indexed by |
MyJurnal (2021) |
H-Index
|
3 |
Immediacy Index
|
0.000 |
Rank |
0 |
Indexed by |
Scopus 2020 |
Impact Factor
|
CiteScore (0.2) |
Rank |
Q4 (Medicine (all)) |
Additional Information |
SJR (0.144) |
|
|
|